Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists), GLP-2R agonists(Glucagon-like peptide 2 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Intestinal Failure | Preclinical | JP | - | |
Nonalcoholic Steatohepatitis | Preclinical | JP | - |